AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know.
To learn more about AMR’s fully integrated network, click here: amrllc.com.
Moist Snuff Tobacco Study
March 9, 2018
The purpose of this research study is to characterize nicotine exposure following the use of two (2) moist snuff tobacco pouch products each over a 7-day period in adult users of loose or pouch moist snuff tobacco.
Duration: Approximately 1.5 months
Number of visits to CKRA: 2 (screening visit plus 15-day…
The purpose of this study is to evaluate the safety and effectiveness (how well a medication works) of an investigational medication for overactive bladder as compared to a marketed medication and a placebo.
Hypoactive Sexual Desire Disorder (HSDD) in Postmenopausal Women
November 16, 2017
The purpose of this study is to confirm the effectiveness of daily intravaginal administration of an prasterone for 28 weeks on Hypoactive Sexual Desire Disorder in postmenopausal women, as compared to a placebo.
The purpose of this study is to find out if an investigational vaccine prevents severe diarrhea caused by a germ (bacterium) called Clostridium difficile (C diff). Vaccines help your body to make antibodies which help to fight against diseases (also called an immune response). C diff is a significant…
Central Kentucky Research Associates will soon be conducting several smoking and tobacco-related clinical research studies, including studies for cigarette and cigar smokers and users of e-cigarettes, e-vapor products and smokeless tobacco products. If you would like to be placed on the waiting list to be contacted about upcoming tobacco-related…